News - Gastro-intestinals, Merck & Co


Popular Filters

Merck & Co to continue posting sales and profits under AstraZeneca partnership


US drug giant Merck & Co (NYSE: MRK) and Anglo-Swedish major AstraZeneca have amended the option agreement…

AstraZenecaFinancialGastro-intestinalsLicensingMerck & CoNexiumPharmaceuticalPrilosec

Merck & Co gets positive CHMP opinion for Remicade in new indication


US drug giant Merck & Co (NYSE: MRK) says that announced that the European Medicines Agency’s Committee…

EuropeGastro-intestinalsMerck & CoPharmaceuticalRegulationRemicade

Regulatory briefs: Allergic reactions warning on Merck & Co’s Saphris; Eisai drops Pariet ER development


The US Food and Drug Administration is warning that serious allergic reactions have been reported with…

EisaiGastro-intestinalsMerck & CoNeurologicalNorth AmericaParietPharmaceuticalRegulationSaphris

Back to top